FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036674906> ?p ?o ?g. }

• W3036674906 abstract "Abstract Background Amblyomma americanum and Rhipicephalus sanguineus ( sensu lato ) nymphs commonly feed on and transmit pathogens to dogs ( Canis familiaris ). Control of immature and adult tick life stages is necessary to fully protect animals. We evaluated efficacy of oral fluralaner (Bravecto ® ) against induced infestations with A. americanum and R. sanguineus ( s.l .) nymphs on dogs in two experiments. Methods In each experiment, 10 dogs were administered oral fluralaner chewable tablets one time on Day 0 at a targeted minimum dose of 25 mg/kg body weight and 10 dogs remained non-treated controls. Dogs were infested with two groups of 50 A. americanum nymphs and two groups of 50 R. sanguineus ( s.l .) nymphs on Days -1, 6, 28, 56 and 84. At 48 h and 72 h post-infestation, nymphs were collected from dogs, assessed as live or dead, and enumerated into categories defining attachment and engorgement status. Fluralaner efficacy was determined in separate analyses against all live nymphs and against live-fed nymphs, i.e. live nymphs that were attached to dogs at the time of collection and/or were engorged. Fluralaner was considered effective when mean numbers of live ticks were reduced in fluralaner-treated dogs by ≥ 90%. Results Fluralaner efficacy against all live and live-fed A. americanum nymphs in the first experiment was > 94% on all collection days. Efficacy against all live R. sanguineus ( s.l .) nymphs in the first experiment was > 96% on all collection days excluding the 48 h counts for infestations on Days 28 (83.7%), 56 (82.9%) and 84 (86.7%); efficacy against live-fed R. sanguineus ( s.l .) nymphs was > 95% on all 48 h/72 h count days. Fluralaner efficacy against all live A. americanum nymphs in the second experiment was > 93% on all collection days for 8 weeks excluding the 48 h count for infestation on Day 56 (87.8%); efficacy against live-fed A. americanum nymphs was > 91% on all count days for 8 weeks. Efficacy against all live R. sanguineus ( s.l .) nymphs in the second experiment was > 91% on all 72 h collection days except for infestations on Days 28 (76.8%) and 56 (86.3%); efficacy against live-fed R. sanguineus ( s.l .) nymphs was 100% on all 72 h count days. Conclusions A single administration of oral fluralaner to dogs is effective against A. americanum and R. sanguineus ( s.l .) nymphs for up to 12 weeks." @default.
• W3036674906 created "2020-06-25" @default.
• W3036674906 creator A5013394498 @default.
• W3036674906 creator A5015023902 @default.
• W3036674906 creator A5043084098 @default.
• W3036674906 creator A5045860342 @default.
• W3036674906 creator A5050682086 @default.
• W3036674906 creator A5058280172 @default.
• W3036674906 creator A5065763451 @default.
• W3036674906 creator A5066064257 @default.
• W3036674906 creator A5087227982 @default.
• W3036674906 date "2020-06-18" @default.
• W3036674906 modified "2023-10-17" @default.
• W3036674906 title "Evaluation of oral fluralaner (Bravecto®) for efficacy against nymphs of Amblyomma americanum and Rhipicephalus sanguineus (sensu lato)" @default.
• W3036674906 cites W1497254863 @default.
• W3036674906 cites W1965282499 @default.
• W3036674906 cites W1969214908 @default.
• W3036674906 cites W1992155930 @default.
• W3036674906 cites W1994057625 @default.
• W3036674906 cites W2025867005 @default.
• W3036674906 cites W2026976118 @default.
• W3036674906 cites W2045196307 @default.
• W3036674906 cites W2074536593 @default.
• W3036674906 cites W2075774945 @default.
• W3036674906 cites W2097807840 @default.
• W3036674906 cites W2143162784 @default.
• W3036674906 cites W2152467528 @default.
• W3036674906 cites W2162572393 @default.
• W3036674906 cites W2166873115 @default.
• W3036674906 cites W2170796118 @default.
• W3036674906 cites W2174332018 @default.
• W3036674906 cites W2323382439 @default.
• W3036674906 cites W2607158519 @default.
• W3036674906 cites W2778932298 @default.
• W3036674906 cites W2794004184 @default.
• W3036674906 cites W2796480630 @default.
• W3036674906 cites W2894963568 @default.
• W3036674906 cites W2912161249 @default.
• W3036674906 cites W2921095439 @default.
• W3036674906 cites W4244525744 @default.
• W3036674906 doi "https://doi.org/10.1186/s13071-020-04179-y" @default.
• W3036674906 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7302130" @default.
• W3036674906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32552774" @default.
• W3036674906 hasPublicationYear "2020" @default.
• W3036674906 type Work @default.
• W3036674906 sameAs 3036674906 @default.
• W3036674906 citedByCount "5" @default.
• W3036674906 countsByYear W30366749062022 @default.
• W3036674906 countsByYear W30366749062023 @default.
• W3036674906 crossrefType "journal-article" @default.
• W3036674906 hasAuthorship W3036674906A5013394498 @default.
• W3036674906 hasAuthorship W3036674906A5015023902 @default.
• W3036674906 hasAuthorship W3036674906A5043084098 @default.
• W3036674906 hasAuthorship W3036674906A5045860342 @default.
• W3036674906 hasAuthorship W3036674906A5050682086 @default.
• W3036674906 hasAuthorship W3036674906A5058280172 @default.
• W3036674906 hasAuthorship W3036674906A5065763451 @default.
• W3036674906 hasAuthorship W3036674906A5066064257 @default.
• W3036674906 hasAuthorship W3036674906A5087227982 @default.
• W3036674906 hasBestOaLocation W30366749061 @default.
• W3036674906 hasConcept C159047783 @default.
• W3036674906 hasConcept C2776127032 @default.
• W3036674906 hasConcept C2776427669 @default.
• W3036674906 hasConcept C2776451879 @default.
• W3036674906 hasConcept C2776534226 @default.
• W3036674906 hasConcept C2779620486 @default.
• W3036674906 hasConcept C33070731 @default.
• W3036674906 hasConcept C42972112 @default.
• W3036674906 hasConcept C59822182 @default.
• W3036674906 hasConcept C71924100 @default.
• W3036674906 hasConcept C74714110 @default.
• W3036674906 hasConcept C85323577 @default.
• W3036674906 hasConcept C86803240 @default.
• W3036674906 hasConcept C90856448 @default.
• W3036674906 hasConceptScore W3036674906C159047783 @default.
• W3036674906 hasConceptScore W3036674906C2776127032 @default.
• W3036674906 hasConceptScore W3036674906C2776427669 @default.
• W3036674906 hasConceptScore W3036674906C2776451879 @default.
• W3036674906 hasConceptScore W3036674906C2776534226 @default.
• W3036674906 hasConceptScore W3036674906C2779620486 @default.
• W3036674906 hasConceptScore W3036674906C33070731 @default.
• W3036674906 hasConceptScore W3036674906C42972112 @default.
• W3036674906 hasConceptScore W3036674906C59822182 @default.
• W3036674906 hasConceptScore W3036674906C71924100 @default.
• W3036674906 hasConceptScore W3036674906C74714110 @default.
• W3036674906 hasConceptScore W3036674906C85323577 @default.
• W3036674906 hasConceptScore W3036674906C86803240 @default.
• W3036674906 hasConceptScore W3036674906C90856448 @default.
• W3036674906 hasIssue "1" @default.
• W3036674906 hasLocation W30366749061 @default.
• W3036674906 hasLocation W30366749062 @default.
• W3036674906 hasLocation W30366749063 @default.
• W3036674906 hasLocation W30366749064 @default.
• W3036674906 hasOpenAccess W3036674906 @default.
• W3036674906 hasPrimaryLocation W30366749061 @default.
• W3036674906 hasRelatedWork W1964367424 @default.
• W3036674906 hasRelatedWork W2015285412 @default.
• W3036674906 hasRelatedWork W2313626503 @default.
• W3036674906 hasRelatedWork W2316476436 @default.
• W3036674906 hasRelatedWork W2329004175 @default.

• next